» Articles » PMID: 24353438

Mitigating the Risk of Opioid Abuse Through a Balanced Undergraduate Pain Medicine Curriculum

Overview
Journal J Pain Res
Publisher Dove Medical Press
Date 2013 Dec 20
PMID 24353438
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic pain is highly prevalent in the United States and Canada, occurring in an estimated 30% of the adult population. Despite its high prevalence, US and Canadian medical schools provide very little training in pain management, including training in the safe and effective use of potent analgesics, most notably opioids. In 2005, the International Association for the Study of Pain published recommendations for a core undergraduate pain management curriculum, and several universities have implemented pilot programs based on this curriculum. However, when outcomes have been formally assessed, these initiatives have resulted in only modest improvements in physician knowledge about chronic pain and its treatment. This article discusses strategies to improve undergraduate pain management curricula and proposes areas in which those efforts can be augmented. Emphasis is placed on opioids, which have great potency as analgesics but also substantial risks in terms of adverse events and the risk of abuse and addiction. The authors conclude that the most important element of an undergraduate pain curriculum is clinical experience under mentors who are capable of reinforcing didactic learning by modeling best practices.

Citing Articles

What are medical students taught about persistent physical symptoms? A scoping review of the literature.

Nagel C, Queenan C, Burton C BMC Med Educ. 2024; 24(1):618.

PMID: 38835003 PMC: 11151618. DOI: 10.1186/s12909-024-05610-z.


Metabolic Fingerprinting for the Diagnosis of Clinically Similar Long COVID and Fibromyalgia Using a Portable FT-MIR Spectroscopic Combined with Chemometrics.

Hackshaw K, Yao S, Bao H, Castellvi S, Aziz R, Nuguri S Biomedicines. 2023; 11(10).

PMID: 37893078 PMC: 10604557. DOI: 10.3390/biomedicines11102704.


Content analysis of chronic pain content at three undergraduate medical schools in Ontario.

Comer L Can J Pain. 2022; 1(1):75-83.

PMID: 35005343 PMC: 8730565. DOI: 10.1080/24740527.2017.1337467.


Assessing our approach to diagnosing Fibromyalgia.

Hackshaw K Expert Rev Mol Diagn. 2020; 20(12):1171-1181.

PMID: 33301346 PMC: 11829810. DOI: 10.1080/14737159.2020.1858054.


Reducing Opioid Overprescribing by Educating, Monitoring and Collaborating with Clinicians: A Quality Improvement Study.

Gupta A, Lindstrom S, Shevatekar G Cureus. 2020; 12(4):e7778.

PMID: 32455084 PMC: 7243611. DOI: 10.7759/cureus.7778.


References
1.
Zhang W, Moskowitz R, Nuki G, Abramson S, Altman R, Arden N . OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008; 16(2):137-62. DOI: 10.1016/j.joca.2007.12.013. View

2.
Murinson B, Nenortas E, Mayer R, Mezei L, Kozachik S, Nesbit S . A new program in pain medicine for medical students: integrating core curriculum knowledge with emotional and reflective development. Pain Med. 2011; 12(2):186-95. PMC: 3078763. DOI: 10.1111/j.1526-4637.2010.01050.x. View

3.
Chen I, Kurz J, Pasanen M, Faselis C, Panda M, Staton L . Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med. 2005; 20(7):593-8. PMC: 1490156. DOI: 10.1111/j.1525-1497.2005.0106.x. View

4.
Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming M . Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006; 22(9):1859-65. PMC: 1959337. DOI: 10.1185/030079906X132398. View

5.
Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A . Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Physician. 2011; 57(11):1269-76, e419-28. PMC: 3215603. View